Personal information

No personal information available

Activities

Collapse all

Works (4)

Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients

International Journal of Gynecological Cancer
2024-10 | Journal article
DOI: 10.1136/ijgc-2024-005363
Contributors: Matteo Bruno; Adriana Ionelia Apostol; Serena Maria Boccia; Carolina Maria Sassu; Sara Lardino; Camilla Culcasi; Domenica Lorusso; Giovanni Scambia; Anna Fagotti; Claudia Marchetti et al.
Source: check_circle
Crossref

Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival?

International Journal of Gynecological Cancer
2024-01 | Journal article
DOI: 10.1136/ijgc-2023-004980
Contributors: Carolina Maria Sassu; Claudia Marchetti; Giorgia Russo; Angelo Minucci; Serena Maria Boccia; Alberto Benato; Camilla Nero; Alessia Piermattei; Pier Paolo Mattogno; Diana Giannarelli et al.
Source: check_circle
Crossref

Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors

International Journal of Gynecological Cancer
2023-06 | Journal article
DOI: 10.1136/ijgc-2022-003903
Contributors: Lucia Musacchio; Serena Boccia; Claudia Marchetti; Angelo Minucci; Floriana Camarda; Chiara Cassani; Jole Ventriglia; Vanda Salutari; Viola Ghizzoni; Elena Giudice et al.
Source: check_circle
Crossref

Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study

International Journal of Gynecological Cancer
2023-02 | Journal article
DOI: 10.1136/ijgc-2022-003764
Contributors: Laura Vertechy; Serena Maria Boccia; Giordana Tiberi; Giacomo Avesani; Giacomo Corrado; Anna Fagotti; Giovanni Scambia; Claudia Marchetti
Source: check_circle
Crossref

Peer review (5 reviews for 1 publication/grant)

Review activity for International journal of gynecological cancer (5)
How many people are using ORCID?